Press release
Deadline on March 24th coming up in Lawsuit for Investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR)
A Deadline is coming up on March 24, 2021 in the lawsuit for certain investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR).
Investors who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) have certain options and there are strict and short deadlines running. Deadline: March 24, 2021. NASDAQ: VYGR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of Voyager Therapeutics, Inc. (NASDAQ: VYGR) common shares between June 1, 2017 and November 9, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 1, 2017 and November 9, 2020, the defendants made false and/or misleading statements and failed to disclose to investors that the Company's VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls ("CMC") matters, including, inter alia, drug-device compatibility and drug substance and product characterization, that the Company's IND submission for VY-HTT01 was therefore deficient, that the Company had thus materially overstated the likelihood of FDA approval for VY-HTT01 based on the IND submission, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on March 24th coming up in Lawsuit for Investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR) here
News-ID: 2254062 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Voyager
Voyager Replaces VMware with Virtuozzo to Regain Control of Cloud Infrastructure
Virtuozzo, the alternative cloud platform built for service providers, today announced that New Zealand-based telecommunications and cloud provider Voyager has successfully transitioned from VMware to Virtuozzo Hybrid Infrastructure - reclaiming full control over its cloud platform, pricing, and customer experience.
A Strategic Shift Towards Simplicity and Sovereignty
Voyager, one of New Zealand's leading ISPs and cloud service providers, had long relied on VMware to deliver hyperconverged infrastructure and cloud services.…
The Healthy Voyager Launches Holistic Travel Supplement Line
Los Angeles, CA - The Healthy Voyager, a leading brand in travel and wellness, has announced the launch of their new Holistic Travel Supplement Product Line. With a mission to help travelers stay healthy and happy on the road, The Healthy Voyager has created a line of vegetarian, vegan, and gluten-free supplements that cater to all types of travelers. The products are made with the highest quality, clean ingredients, allowing…
NO-BOundaries Voyager 1 E-Bike Launched on Indiegogo
Elevate Your Ride with Style, Safety, and Innovation
Image: https://www.abnewswire.com/uploads/b31b033407f6168d86dfeb385d0b0fed.PNG
NO-BOundaries launched today on Indiegogo Voyager 1, an e-bike crafted over a meticulous two-year period by a dedicated team to transcend the conventional notion of e-bikes. The campaign describes this e-bike as "not only a mode of transportation but a statement piece reflecting the user's lifestyle and personality."
One of the key features of the Voyager 1 is its integrated 360 lighting system,…
Digital Currency Trading Platform Market is Booming Worldwide | Coinbase, Binanc …
Latest Study on Industrial Growth of Digital Currency Trading Platform Market 2022-2028. A detailed study accumulated to offer Latest insights about acute features of the Digital Currency Trading Platform market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the…
Investigation announced for Investors in shares of Voyager Therapeutics, Inc. (N …
Voyager Therapeutics, Inc. are under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Voyager Therapeutics, Inc. regarding its business, its prospects and its operations were materially false…
Ataxia Therapeutics Pipeline Analysis 2018 | Reata Pharmaceuticals, Inc., Voyage …
Ataxia is a type of movement disorder characterized by lack of muscle control or coordination of voluntary movements. Some of the symptoms observed in the patients with ataxia are poor coordination, change in speech, difficulty in swallowing, and unsteady walk.
Download the sample report @ https://www.pharmaproff.com/request-sample/1078
The disease causes include head injury; stroke; autoimmune diseases, such as sarcoidosis and multiple sclerosis; paraneoplastic syndromes; and viral infections. The disease is also found in…
